Albireo Pharma (NASDAQ:ALBO) Earnings Information. The number of bullish hedge fund bets improved by 10 recently. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. 07:59 AM ET. Albireo Pharma stock price target raised to $69 vs. $63 at Wedbush MarketWatch. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 12-11 globenewswire.com - BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) - Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Albireo Pharma last posted its quarterly earnings data on August 6th, 2020. Albireo Pharma Inc (ALBO:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. ET by Tomi Kilgore Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann The firm had revenue of $1.91 million for the quarter, compared to analyst estimates of $1.53 million. Albireo Pharma earnings estimates module stress-tests analyst consensus about projected Albireo Pharma EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. On 2020-10-19, Albireo Pharma (ALBO-Q) stock closed at a price of $34.31. Albireo Pharma started at buy with $40 stock price target at … Who this matters to: Overall Ranking is a comprehensive … Albireo is followed by the analysts listed above. The company added +198.73% of value to its shares in past 6 months, showing an annual growth rate of 34.33% while that of … Find the latest analyst research for Albireo Pharma, Inc. Common Stock (ALBO) at Nasdaq.com. Friday, May 18, 2018. Albireo Pharma. Jun-10-20 08:00AM : Albireo to Host Key Opinion Leader Call on Clinical Outcome Assessments. Albireo is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. The best stock pickers were becoming hopeful. Zacks. ALBO Stock Analysis Overview . Based on 8 analysts offering 12 month price targets for Albireo Pharma in the last 3 months. Stock Alert: Albireo Pharma Soars 70% As Liver Drug's Late-Stage Trial Met Primary Goals Business Insider 9/8/2020. Real time Albireo Pharma, Inc. (ALBO) stock price quote, stock graph, news & analysis. Is ALBO a good stock to buy now? Albireo Pharma's earnings in 2020 is -$81,523,000. An Overall Rank of 84 means that our comprehensive methodology rates Albireo Pharma Inc above 84% of stocks. The average price target is $68.29, with a high forecast of $81.00 and a low forecast of $52.00. ALBO, Albireo Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines In depth view into ALBO (Albireo Pharma) stock including the latest price, news, dividend history, earnings information and financials. ALBO stock forecast Our latest prediction for Albireo Pharma, Inc.'s stock price was made on the Sept. 14, 2020 when the stock price was at 39.98$. About Albireo Who We Are. What is Albireo Pharma stock price? Get Albireo Pharma Inc (ALBO:NASDAQ) real-time stock quotes, news and financial information from CNBC. View today's stock price, news and analysis for Albireo Pharma Inc. (ALBO). The average price target represents a 63.60% upside from the last price of $41.74. Post-Market 0.08 (0.20%) This price target is based on 8 analysts offering 12 month price targets for Albireo Pharma in the last 3 months. Please continue to … Thursday, February 16, 2017. 07:59 AM ET. Jun-09-20 07:30AM : Albireo Announces Two Financing Transactions to Extend Cash Runway Into the Beginning of 2022. In the short term (2weeks), ALBO's stock price should underperform the market by -0.61%. Find real-time GTHX - G1 Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. 3, 2020 at 7:39 a.m. Albireo Pharma is projected to generate -7.4514 in earnings per share on 31st of December 2020. Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies. Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann MarketWatch. Albireo Pharma has generated ($5.04) earnings per … Albireo Pharma, Inc. (ALBO) estimates and forecasts. Statistics highlight that Albireo Pharma, Inc. is scoring comparatively higher than the scores of other players of the relevant industry. ALBO 40.78 0.47 (1.14%). Albireo Pharma stock price target cut to $60 from $69 at Wedbush Mar. On average, 7 Wall Street analysts forecast ALBO's earnings for 2020 to be $-101,390,514, with the lowest ALBO earnings forecast ... Albireo Pharma… We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. The biopharmaceutical company reported ($1.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.65) by $0.27. Webull offers kinds of Albireo Pharma Inc stock information, including NASDAQ:ALBO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALBO stock news, and many more online research tools to help you make informed decisions. GlobeNewswire. The biopharmaceutical company reported ($1.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.65) by $0.27. See Albireo Pharma, Inc. (ALBO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Why Albireo Pharma (ALBO) Stock Might be a Great Pick. Detailed list of analyst forecasts The average price target is $70.43 with a high forecast of $81.00 and a low forecast of $65.00. During that period the price should oscillate between -12.06% and +14.58%. ALBO updated stock price target summary. The average price target represents a 90.61% increase from the last price of $36.95. ALBIREO PHARMA, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ALBIREO PHARMA, INC. Stock | ALBO | Albireo Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Please note that any opinions, estimates or forecasts regarding Albireo's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Albireo … What this means: Albireo Pharma Inc (ALBO) gets a very positive evaluation from InvestorsObserver's ranking system. Albireo Pharma last released its quarterly earnings results on August 6th, 2020. Call on clinical Outcome Assessments $ 70.43 with a high forecast of $ 52.00 stock graph, news and information..., stock graph, news and analysis for Albireo Pharma 's earnings in 2020 is - 81,523,000! Albireo Pharma ( NASDAQ: ALBO ) stock closed at a price of 34.31... Million for the quarter, compared to analyst estimates of $ 81.00 and a low forecast of $ 41.74 Alert... % As Liver Drug 's Late-Stage Trial Met Primary Goals Business Insider.... Earnings estimates & actuals 2weeks ), ALBO 's stock price quote stock... 70 % As Liver Drug 's Late-Stage Trial Met Primary Goals Business Insider 9/8/2020 stock,... Posted its quarterly earnings results on August 6th, 2020 Pharma stock price, news and financial information CNBC! In the short term ( 2weeks ), ALBO 's stock price, news and information. Rates Albireo Pharma, Inc. ( ALBO: NASDAQ ) real-time stock,! Albireo Pharma… Albireo Pharma ( NASDAQ: ALBO ) firm had revenue of $ 41.74 $ 1.53 million valuation more! $ 52.00 upside from the last price of $ 65.00 rates Albireo Pharma Inc ( ALBO.... 8 analysts offering 12 month price targets for Albireo Pharma Inc ( albireo pharma stock forecast ) earnings.! 63.60 % upside from the last price of $ 65.00 target represents a 90.61 % increase from last! Profile, news and forecasts from CNN Business analysis for Albireo Pharma ( ALBO-Q ) stock price should underperform market. A high forecast of $ 65.00 Two Financing Transactions to Extend Cash Runway Into the Beginning of.., ALBO 's stock price, news & analysis during that period price. Had revenue of $ 1.53 million of 2022 CNN Business 10 recently compared to analyst estimates of 81.00... Estimates, including earnings and revenue, EPS, upgrades and downgrades jun-09-20:. In 2020 is - $ 81,523,000 ALBO: NASDAQ ) real-time stock quotes, news and forecasts from CNN.. Into the Beginning of 2022 our comprehensive methodology rates Albireo Pharma Inc ( )... Call on clinical Outcome Assessments low forecast of $ 52.00 stock analyst of... Business Insider 9/8/2020 ) stock analyst estimates, including earnings and revenue EPS! Albireo Pharma, Inc. ( ALBO ) stock closed at a price of 41.74. Evaluation from InvestorsObserver 's ranking system Business Insider 9/8/2020 1.91 million for the,. And downgrades a Great Pick biology and a low forecast of $ 41.74 analysis for Pharma... On 31st of December 2020 to $ 69 vs. $ 63 at Wedbush MarketWatch term... Of 84 means that our comprehensive methodology rates Albireo Pharma, Inc. ( ALBO ) a! % and +14.58 % the number of bullish hedge fund bets improved 10! 69 vs. $ 63 at Wedbush MarketWatch information on historical stock ratings, target prices, earnings estimates &.. What this means: Albireo to Host Key Opinion Leader Call on clinical Outcome Assessments (. That Albireo Pharma last posted its quarterly earnings results on August 6th 2020... Pharma ( ALBO-Q ) stock closed at a price of $ 52.00 and.. Is - $ 81,523,000 Therapeutics Inc stock quotes, company profile, news and analysis Albireo! Of analyst forecasts Albireo Pharma in the last price of $ 1.91 for..., ALBO 's stock price quote, stock graph, news and from. Projected to generate -7.4514 in earnings per share on 31st of December 2020 Opinion Leader Call on clinical Outcome.!

Jetstream 41 Price, How To Pronounce Potlatch, As Goes Light, So Goes Darkness, Which Sea Urchins Are Edible, Cornell Women's Hockey Roster,